Developer docs
API playgroundTry for free, no card

Search company profiles

PharmStars

Full company profile

uuid0006fel

Namestring
PharmStars
Legal namestring
PharmStars
Websiteurl
pharmstars.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

PharmStars is a Boston-based, pharma-focused accelerator for digital health startups founded in June 2021 by Naomi Fried, PhD and Laura Gunn, PhD. The company operates a 10-week themed cohort program called PharmaU, run twice per year (Spring and Fall), with each cohort focused on a specific therapeutic or operational area such as Oncology, Clinical Trials, Rare Disease, Women's Health, Real-World Evidence, Immunology, and Operations & Outcomes. The program combines a structured pharma curriculum, individualized mentoring from in-house former pharma executives, and an Executive Ed component for pharma leadership, culminating in a private Startup Showcase Event held in Boston where graduates pitch to and hold one-on-one meetings with paying pharma members.

PharmStars monetizes primarily through annual pharma membership fees paid by enterprise pharmaceutical firms — publicly identified members include Boehringer Ingelheim, Eli Lilly, Takeda (founding 2021), Roche (2022), and Sumitovant Biopharma — in exchange for exclusive, curated access to the startup cohort pipeline. Digital health startups apply globally through a competitive selection process and participate in cohorts that have attracted applicants from 40+ countries. In 2025 the firm extended its model with the launch of PharmStars Ventures, a venture fund co-founded by Naomi Fried and Shrawan Patel, MD as General Partners that invests exclusively in accelerator alumni and holds 23+ portfolio positions. The broader operating stack includes Graduate School programming for ongoing alumni engagement and, as of May 2026, the inaugural PharmTech Innovation Summit in Boston.

Across ten completed cohorts, PharmStars has graduated 112+ digital health startups with a 99% completion rate; alumni have collectively raised over $1B in funding and, among the first 35 graduates, have secured 100+ pharma deals. The firm is headquartered at 661 Commonwealth Avenue, Newton, Massachusetts, operates with a small team of under 10 employees, and has no publicly disclosed institutional funding rounds, indicating it has been funded primarily through operating revenues from pharma membership.

Short descriptiontext

PharmStars is a Boston-based digital health accelerator that runs themed 10-week PharmaU cohorts twice yearly, educating startups and providing paying pharma members like Boehringer Ingelheim, Eli Lilly, Takeda, and Roche with curated access to startups through a private Showcase Event.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health accelerator, pharma startup education, healthcare mentorship programs, digital therapeutics partnerships, pharma innovation programs
Industry2 codes
PRIMARYFSANAHAD
Corporate Accelerators & Startup Programs
SECONDARYEDABALAU
Pharmaceuticals & Biotechnology
Education/Corporate Training & Professional Development/Industry-Specific Professional Training (e.g., Healthcare, Manufacturing, Construction)
NAICS code1 code
  • Business Schools and Computer and Management Training6114
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Digital Health Accelerator Services
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Pharma Membership Fees
TypeSubscription Recurring
Description

Pharma companies pay membership fees to join PharmStars, gaining exclusive access to curated digital health startups, participation in the Showcase Event, and engagement through Executive Ed programming. Pharma members commit to working with startups that graduate from the accelerator.

pharmstars.com
2Accelerator Program Participation Fees
TypeProfessional Services
Description

Digital health startups apply and are selected to participate in the 10-week PharmaU cohort. While specific tuition is not publicly disclosed, startups benefit from education, mentoring, and direct access to pharma members at the Showcase Event.

pharmstars.com
3PharmStars Ventures Investment Returns
TypeLicensing Royalties
Description

PharmStars Ventures, a venture fund wrapping around the accelerator, invests in PharmStars alumni companies. Returns on investment in portfolio companies generate revenue for the fund's general partners.

pharmstars.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Pharma Membership — access to curated startups, Showcase Event, Executive Ed, and one-on-one meetings
ModelSubscriptionBilling cadenceAnnual
Notes

Membership details and fees not publicly disclosed. Pharma members include Boehringer Ingelheim, Eli Lilly, Takeda, Roche, Sumitovant, and others.

pharmstars.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1PharmaU
Description

The centerpiece educational program of PharmStars accelerator consisting of curriculum for startups, mentoring, and Executive Education for pharma leadership

pharmstars.com
+3 more records
Core offering1 text field

PharmStars operates a 10-week PharmaU accelerator program for digital health startups, providing a structured pharma-focused curriculum covering drug development, regulatory drivers, and pharma-startup deal structures. The program includes individualized mentoring from former pharma executives, executive education for pharma members, and culminates in a private Startup Showcase event where startups pitch to and meet one-on-one with multiple pharma companies. Additional offerings include the Graduate School alumni program and PharmStars Ventures, a venture fund investing in accelerator graduates.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 99% graduation rate across all cohorts
+5 more records
Product overview1 text field

PharmStars is a pharma-focused accelerator for digital health startups, offering a 10-week accelerator program as its core offering. The main product is PharmaU, an educational program with three components: a curriculum for startups, personalized mentoring, and Executive Education for pharma leadership. The accelerator culminates with a Startup Showcase event. Additional offerings include PharmStars Ventures (a venture fund for graduates) and Graduate School (ongoing alumni support).

Product and service5 records
1PharmStars Accelerator (PharmaU Program)
CategoryDigital Health Accelerator
2Startup Showcase Event
CategoryIndustry Event / Partnership Forum
3PharmStars Ventures
CategoryVenture Capital Fund
4Graduate School
CategoryAlumni Programming / Continuing Education
5PharmTech Innovation Summit
CategoryIndustry Conference
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-06-15
Description

Roche joined PharmStars as a pharma member, gaining exclusive access to curated digital health startups through the Showcase Event and ongoing engagement with the accelerator's alumni community.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-11-03
Description

Sumitovant Biopharma joined PharmStars as a member, participating in the accelerator to connect with digital health startups. Sumitovant's Chief Medical Officer Sam Azoulay also serves as a Mentor Advisor to PharmStars.

3Boehringer Ingelheim
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-06-30
Description

Boehringer Ingelheim is a founding member of PharmStars, participating as a pharma member since the accelerator's public launch in June 2021. As a member, Boehringer Ingelheim gains access to curated digital health startups for potential partnerships and collaboration.

pharmstars.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-06-30
Description

Eli Lilly and Company is a founding member of PharmStars, participating as a pharma member since the accelerator's public launch in June 2021. Lilly engages with startups through the Showcase Event and one-on-one meetings, exploring digital health partnerships aligned with its innovation strategy.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-06-30
Description

Takeda is a founding member of PharmStars, participating as a pharma member since the accelerator's public launch in June 2021. Takeda engages with PharmStars startups to explore digital health solutions that complement its therapeutic focus areas.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Novartis' digital health innovation hub runs accelerator-style programs that connect digital health startups with pharma stakeholders. Direct competition for digital health startups seeking pharma partnerships.

TypeDirect peer
Description

Bayer's digital health accelerator offers pharma-sponsored programming for health startups and is a direct competitor for both pharma member mind-share and startup applicants. Comparable cohort-based model connecting pharma with digital health ventures.

TypeDirect peer
Description

J&J's life sciences incubator network operates pharma-backed accelerator programming across multiple therapeutic areas. Highly comparable in serving as a neutral pharma-adjacent platform for healthcare startups seeking enterprise partnerships.

4Pfizer Healthcare Hub
TypeDirect peer
Description

Pfizer's healthcare hub supports digital health and patient-centric startups through partnership programming. Comparable pharma-led accelerator targeting the same startup-pharma engagement gap.

TypeDirect peer
Description

Merck's digital sciences studio incubates biotech and digital health startups with pharma resources. Similar model offering pharma-backed infrastructure and mentorship to digital health ventures.

TypeDirect peer
Description

HealthTech-focused accelerator partnering with industry sponsors to drive digital health innovation. Comparable cohort-based model serving startups seeking enterprise healthcare partnerships.

TypeDirect peer
Description

Corporate-backed accelerator program with a dedicated health vertical running themed batches for digital health startups. Comparable cohort structure and pharma/healthcare member model.

TypeDirect peer
Description

Global digital health accelerator running cohort-based programs for early-stage healthcare ventures with corporate partner access. Direct competition for digital health startup applicants.

TypeOthers
Description

Healthcare IT industry organization with innovation programming, accelerators, and venture connections. Adjacent ecosystem participant that serves similar audiences (pharma, digital health startups, providers) and overlaps with PharmStars' market.

TypeOthers
Description

Healthcare technology industry alliance connecting startups with healthcare enterprise stakeholders. Comparable in facilitating enterprise-startup partnerships in the digital health space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment69 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmStars

Digital Health Accelerator Servicespharmstars.com

PharmStars is a Boston-based digital health accelerator that runs themed 10-week PharmaU cohorts twice yearly, educating startups and providing paying pharma members like Boehringer Ingelheim, Eli Lilly, Takeda, and Roche with curated access to startups through a private Showcase Event.

What PharmStars does

PharmStars is a Boston-based, pharma-focused accelerator for digital health startups founded in June 2021 by Naomi Fried, PhD and Laura Gunn, PhD. The company operates a 10-week themed cohort program called PharmaU, run twice per year (Spring and Fall), with each cohort focused on a specific therapeutic or operational area such as Oncology, Clinical Trials, Rare Disease, Women's Health, Real-World Evidence, Immunology, and Operations & Outcomes. The program combines a structured pharma curriculum, individualized mentoring from in-house former pharma executives, and an Executive Ed component for pharma leadership, culminating in a private Startup Showcase Event held in Boston where graduates pitch to and hold one-on-one meetings with paying pharma members.

PharmStars monetizes primarily through annual pharma membership fees paid by enterprise pharmaceutical firms — publicly identified members include Boehringer Ingelheim, Eli Lilly, Takeda (founding 2021), Roche (2022), and Sumitovant Biopharma — in exchange for exclusive, curated access to the startup cohort pipeline. Digital health startups apply globally through a competitive selection process and participate in cohorts that have attracted applicants from 40+ countries. In 2025 the firm extended its model with the launch of PharmStars Ventures, a venture fund co-founded by Naomi Fried and Shrawan Patel, MD as General Partners that invests exclusively in accelerator alumni and holds 23+ portfolio positions. The broader operating stack includes Graduate School programming for ongoing alumni engagement and, as of May 2026, the inaugural PharmTech Innovation Summit in Boston.

Across ten completed cohorts, PharmStars has graduated 112+ digital health startups with a 99% completion rate; alumni have collectively raised over $1B in funding and, among the first 35 graduates, have secured 100+ pharma deals. The firm is headquartered at 661 Commonwealth Avenue, Newton, Massachusetts, operates with a small team of under 10 employees, and has no publicly disclosed institutional funding rounds, indicating it has been funded primarily through operating revenues from pharma membership.

PharmStars firmographics

Firmographics
Name
PharmStars
Legal name
PharmStars
Website
https://pharmstars.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
PharmStars is a Boston-based digital health accelerator that runs themed 10-week PharmaU cohorts twice yearly, educating startups and providing paying pharma members like Boehringer Ingelheim, Eli Lilly, Takeda, and Roche with curated access to startups through a private Showcase Event.
Ownership category
akta.pro rank

PharmStars industry classification

Industry
Product category
Digital Health Accelerator Services
NAICS
Business Schools and Computer and Management Training (6114)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYFSANAHAD
Corporate Accelerators & Startup Programs
SECONDARYEDABALAU
Pharmaceuticals & Biotechnology
Education/Corporate Training & Professional Development/Industry-Specific Professional Training (e.g., Healthcare, Manufacturing, Construction)

Keywords

  • Digital health accelerator
  • Pharma startup education
  • Healthcare mentorship programs
  • Digital therapeutics partnerships
  • Pharma innovation programs

Where PharmStars is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

PharmStars business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Pharma Membership Fees: Pharma companies pay membership fees to join PharmStars, gaining exclusive access to curated digital health startups, participation in the Showcase Event, and engagement through Executive Ed programming. Pharma members commit to working with startups that graduate from the accelerator.
  2. Accelerator Program Participation Fees: Digital health startups apply and are selected to participate in the 10-week PharmaU cohort. While specific tuition is not publicly disclosed, startups benefit from education, mentoring, and direct access to pharma members at the Showcase Event.
  3. PharmStars Ventures Investment Returns: PharmStars Ventures, a venture fund wrapping around the accelerator, invests in PharmStars alumni companies. Returns on investment in portfolio companies generate revenue for the fund's general partners.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualPharma Membership — access to curated startups, Showcase Event, Executive Ed, and one-on-one meetings

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

PharmStars product offering

Product offering

Core offering

PharmStars operates a 10-week PharmaU accelerator program for digital health startups, providing a structured pharma-focused curriculum covering drug development, regulatory drivers, and pharma-startup deal structures. The program includes individualized mentoring from former pharma executives, executive education for pharma members, and culminates in a private Startup Showcase event where startups pitch to and meet one-on-one with multiple pharma companies. Additional offerings include the Graduate School alumni program and PharmStars Ventures, a venture fund investing in accelerator graduates.

Product overview

PharmStars is a pharma-focused accelerator for digital health startups, offering a 10-week accelerator program as its core offering. The main product is PharmaU, an educational program with three components: a curriculum for startups, personalized mentoring, and Executive Education for pharma leadership. The accelerator culminates with a Startup Showcase event. Additional offerings include PharmStars Ventures (a venture fund for graduates) and Graduate School (ongoing alumni support).

Differentiator

Problem solved

Functional benefit

Brands

  • PharmaU: The centerpiece educational program of PharmStars accelerator consisting of curriculum for startups, mentoring, and Executive Education for pharma leadership
  • PharmStars Ventures
  • Graduate School
  • Executive Ed

Products and services

  • PharmStars Accelerator (PharmaU Program)
  • Startup Showcase Event
  • PharmStars Ventures
  • Graduate School
  • PharmTech Innovation Summit

Quantifiable outcome

  • 99% graduation rate across all cohorts
  • +5 more outcomes

Companies that use PharmStars

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

PharmStars technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

PharmStars partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • RochecoreStrategic or Co-development Partner · 15 June 2022Roche joined PharmStars as a pharma member, gaining exclusive access to curated digital health startups through the Showcase Event and ongoing engagement with the accelerator's alumni community.
  • Sumitovant BiopharmacoreStrategic or Co-development Partner · 3 November 2021Sumitovant Biopharma joined PharmStars as a member, participating in the accelerator to connect with digital health startups. Sumitovant's Chief Medical Officer Sam Azoulay also serves as a Mentor Advisor to PharmStars.
  • Boehringer IngelheimcoreStrategic or Co-development Partner · 30 June 2021Boehringer Ingelheim is a founding member of PharmStars, participating as a pharma member since the accelerator's public launch in June 2021. As a member, Boehringer Ingelheim gains access to curated digital health startups for potential partnerships and collaboration.
  • Eli Lilly and CompanycoreStrategic or Co-development Partner · 30 June 2021Eli Lilly and Company is a founding member of PharmStars, participating as a pharma member since the accelerator's public launch in June 2021. Lilly engages with startups through the Showcase Event and one-on-one meetings, exploring digital health partnerships aligned with its innovation strategy.
  • TakedacoreStrategic or Co-development Partner · 30 June 2021Takeda is a founding member of PharmStars, participating as a pharma member since the accelerator's public launch in June 2021. Takeda engages with PharmStars startups to explore digital health solutions that complement its therapeutic focus areas.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

PharmStars competitors and assessment

Company assessment

Direct peers

  • Novartis Biome: Novartis' digital health innovation hub runs accelerator-style programs that connect digital health startups with pharma stakeholders. Direct competition for digital health startups seeking pharma partnerships.
  • Bayer G4A: Bayer's digital health accelerator offers pharma-sponsored programming for health startups and is a direct competitor for both pharma member mind-share and startup applicants. Comparable cohort-based model connecting pharma with digital health ventures.
  • Johnson & Johnson Innovation – JLABS: J&J's life sciences incubator network operates pharma-backed accelerator programming across multiple therapeutic areas. Highly comparable in serving as a neutral pharma-adjacent platform for healthcare startups seeking enterprise partnerships.
  • Pfizer Healthcare Hub: Pfizer's healthcare hub supports digital health and patient-centric startups through partnership programming. Comparable pharma-led accelerator targeting the same startup-pharma engagement gap.
  • Merck Digital Sciences Studio: Merck's digital sciences studio incubates biotech and digital health startups with pharma resources. Similar model offering pharma-backed infrastructure and mentorship to digital health ventures.
  • MassChallenge HealthTech: HealthTech-focused accelerator partnering with industry sponsors to drive digital health innovation. Comparable cohort-based model serving startups seeking enterprise healthcare partnerships.
  • Plug and Play Health: Corporate-backed accelerator program with a dedicated health vertical running themed batches for digital health startups. Comparable cohort structure and pharma/healthcare member model.
  • Startupbootcamp Digital Health: Global digital health accelerator running cohort-based programs for early-stage healthcare ventures with corporate partner access. Direct competition for digital health startup applicants.

Others

  • HIMSS (Healthcare Information and Management Systems Society): Healthcare IT industry organization with innovation programming, accelerators, and venture connections. Adjacent ecosystem participant that serves similar audiences (pharma, digital health startups, providers) and overlaps with PharmStars' market.
  • Healthtech Alliance: Healthcare technology industry alliance connecting startups with healthcare enterprise stakeholders. Comparable in facilitating enterprise-startup partnerships in the digital health space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

PharmStars social profiles

Digital presence

PharmStars financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmStars leadership team

Management profile

Number of profiles

Profiles5 records

PharmStars subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

PharmStars funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmStars M&A and investment

M&A and investment

M&A

Investments69 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmStars

What does PharmStars do?

PharmStars operates a 10-week PharmaU accelerator program for digital health startups, providing a structured pharma-focused curriculum covering drug development, regulatory drivers, and pharma-startup deal structures. The program includes individualized mentoring from former pharma executives, executive education for pharma members, and culminates in a private Startup Showcase event where startups pitch to and meet one-on-one with multiple pharma companies. Additional offerings include the Graduate School alumni program and PharmStars Ventures, a venture fund investing in accelerator graduates.

Is PharmStars a public or private company?

PharmStars is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PharmStars founded?

PharmStars was founded in 2021. It employs 1 to 10 people.

Where is PharmStars based?

PharmStars is headquartered in Boston, United States, in the North America region.

How does PharmStars make money?

Three revenue lines are on record. Pharma Membership Fees are the primary driver. The others are accelerator Program Participation Fees and pharmStars Ventures Investment Returns.

Who are PharmStars's main competitors?

Direct peers on record are Novartis Biome, Bayer G4A, Johnson & Johnson Innovation – JLABS, Pfizer Healthcare Hub, Merck Digital Sciences Studio, MassChallenge HealthTech, Plug and Play Health and Startupbootcamp Digital Health. Others are HIMSS (Healthcare Information and Management Systems Society) and Healthtech Alliance.

Does PharmStars have an API?

No public API is recorded for PharmStars.

What industry is PharmStars in?

PharmStars's product category is Digital Health Accelerator Services. Its primary akta.pro industry code is FSANAHAD, Corporate Accelerators & Startup Programs, with a secondary code of EDABALAU, Pharmaceuticals & Biotechnology. Its NAICS code is 6114 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswirePharmStars Announces Cromodata is the First Startup from Argentina to Graduate from its AcceleratorCromodata, an Argentina-based startup, graduated from PharmStars' accelerator, becoming the first Argentinian to do so. The company operates a real-world clinical data platform integrating patient data from 89 hospitals across eight Latin American countries, having validated 50 million records. PharmStars will accept applications for its next cohort in early 2027.EIN PresswirePharmStars Ventures Expands Digital Health Portfolio to 23 with 11 New Investments Bridging the ‘Pharma-Startup Gap’PharmStars Ventures announced 11 new investments in digital health startups from its accelerator's Fall 2025 cohort, bringing its total portfolio to 23 companies. The investments focus on AI, data management, clinical research, real-world data, wearables, and drug discovery innovations across North America, Europe, and South America. The fund leverages its accelerator model to identify, vet, and de-risk startups before investing, with companies having collectively raised over $1 billion and formed over 100 pharma partnerships.EIN PresswirePharmStars Announces Spring 2026 Graduates: 10 Digital Health Startups Complete PharmStars’ Pharma-focused AcceleratorPharmStars announced the graduation of 10 digital health startups from its Spring 2026 accelerator cohort focused on "Digital Innovations in Operations & Outcomes" at a Startup Showcase in Boston. The cohort was PharmStars' 10th and attracted applicants from 21 countries, with nearly 60 one-on-one meetings arranged between startups and pharma members. The program included startups offering AI solutions for drug lifecycle extension, clinical trial management, patient engagement, quality investigations, and regulatory compliance.pharmaphorumHow pharma and start-ups are working together for AI successPharmStars held its inaugural PharmTech Innovation Summit in Boston, bringing together pharma executives and start-up founders to discuss best practices for developing AI partnerships. Speakers emphasized that successful collaborations require co-creation rather than one-sided pitches, highlighting challenges such as pharma's complex buyer-user decision-maker ecosystem, the importance of internal champions with budget access, and defined KPIs for transitioning from pilot to full-scale deployment. Panelists noted that pharma industry attitudes toward AI have shifted from skepticism to urgency, particularly driven by the Inflation Reduction Act's drug pricing negotiations creating increased demand for AI-driven drug discovery.Florida TodayPharmStars’ Tenth Cohort to Focus on ‘Digital Innovations in Operations & Outcomes’PharmStars, the pharma-focused accelerator for digital health startups, announced it is accepting applications for its Spring 2026 cohort focused on 'Digital Innovations in Operations and Outcomes,' marking the accelerator's tenth cohort.EIN PresswirePharmStars Announces Fall 2025 Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-focused AcceleratorPharmStars, a pharma-focused accelerator for digital health startups, announced the graduation of 11 startups from its Fall 2025 cohort focused on 'Innovations in Data Management and Insights.' The 10-week PharmaU program, which attracted applicants from 19 countries, culminated in a Pharmatech Innovation Summit in Boston featuring over 70 one-on-one startup/pharma meetings. This cohort marks the milestone of over 100 startups graduating from PharmStars' accelerator since its inception.LinkedInRequest your invite for the PharmStars Pharmatech Innovation Summit!PharmStars will host an exclusive Pharmatech Innovation Summit in Boston from November 17–19, 2025, featuring 11 digital health startups. The event focuses on AI, data management, and insights, with networking and workshops for pharma leaders. Invitations are requested via a provided link.LinkedIn#pharmatech #pharmaceuticalinnovation #digitalhealth #pharmstarssummit #networking #rookROOK will present at the PharmStars Pharmatech Innovation Summit in Boston, November 17-19, on data management and insights. The event brings together biopharma leaders, digital health startups, and investors, with early-bird pricing ending October 1.American City Business JournalsPharmStars seeks rare disease startups for spring 2025PharmStars is accepting applications for its eighth cohort on digital innovations in rare diseases, with the spring 2025 cohort being the first to receive $150,000 in funding from PharmStars Ventures Fund. The program will accept 10-12 startups with products or prototypes, and applications are due by Jan. 26.In VivoPharmStars’ Founder Aims To Bridge ‘Pharma Start-Up Gap’; Alumni Are Ready To Pounce On Pharma DealPharmStars, a Boston-based virtual accelerator co-founded by Naomi Fried, bridges the gap between digital health start-ups and pharmaceutical companies through its PharmaU training program. The latest cohort showcased innovations to major pharma members including Eli Lilly, Alexion Pharmaceuticals, Novo Nordisk Pharma, Genmab, and Boehringer Ingelheim during a November event in Boston. Since 2021, the accelerator reports that its graduates have secured 98 deals with pharma and biotech firms and collectively raised over $900 million.